secwatch / observer
8-K filed August 26, 2022, 7:59 PM ET ticker WGS CIK 0001818331
leadership confidence high sentiment neutral materiality 0.60

Sema4 names Kevin Feeley CFO as interim CFO Richard Miao departs

GeneDx Holdings Corp.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin Feeley

Chief Financial Officer
WGS · GeneDx Holdings Corp.
Effective
2022-08-25
Filed
August 26, 2022, 7:59 PM ET
On August 25, 2022, Kevin Feeley, the Company’s current Senior Vice President of Operations and Head of GeneDx, was appointed to also serve as the Chief Financial Officer, effective August 25, 2022.
Departed (interim)

Richard Miao

Interim Chief Financial Officer and Deputy Chief Financial Officer
WGS · GeneDx Holdings Corp.
Effective
2022-09-02
Successor
Kevin Feeley
Filed
August 26, 2022, 7:59 PM ET
On August 26, 2022, Sema4 Holdings Corp. (“Sema4 Holdings” or the “Company”) announced that its Interim Chief Financial Officer and Deputy Chief Financial Officer, Richard Miao, will leave the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin Feeley was appointed as Chief Financial Officer at GeneDx Holdings Corp..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On August 25, 2022, Kevin Feeley, the Company’s current Senior Vice President of Operations and Head of GeneDx, was appointed to also serve as the Chief Financial Officer, effective August 25, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Miao departed as Interim Chief Financial Officer and Deputy Chief Financial Officer at GeneDx Holdings Corp..

Action
will leave
Role
Interim Chief Financial Officer and Deputy Chief Financial Officer
Exact text from the filing
On August 26, 2022, Sema4 Holdings Corp. (“Sema4 Holdings” or the “Company”) announced that its Interim Chief Financial Officer and Deputy Chief Financial Officer, Richard Miao, will leave the Company.
View on SEC.gov

GeneDx Holdings Corp. filing history →

Source: SEC EDGAR
accession 0001628280-22-023779
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.